Valuation: Alcon

Market Cap 3.4TCr 2.96TCr 2.76TCr 2.53TCr 4.78TCr 3,24400Cr 4.86TCr 33TCr 13TCr 1,61800Cr 13TCr 12TCr 5,33600Cr P/E 2026 *
32.3x
P/E 2027 * 24.8x
Enterprise Value 3.66TCr 3.18TCr 2.97TCr 2.73TCr 5.14TCr 3,49100Cr 5.23TCr 35TCr 14TCr 1,74100Cr 14TCr 13TCr 5,74200Cr EV / Sales 2026 *
3.29x
EV / Sales 2027 * 3.01x
Free-Float
97.36%
Yield 2026 *
0.52%
Yield 2027 * 0.59%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+13.82%0.00% - - 3.34TCr
+3.38%+2.54%-33.57%-2.96% 8.67TCr
+2.64%+5.61%+4.74%-23.83% 1.41TCr
+1.24%+2.24% - - 1.02TCr
+7.21%+15.86%-22.78%+573.96% 195.2Cr
+0.87%+9.56%-35.83%-65.26% 152.02Cr
+0.70%+11.65%-31.41%-24.61% 89Cr
-1.15%-2.44%+44.95%-28.55% 81Cr
+9.88%+7.39%+16.15%+2.59% 77Cr
+0.67%+8.93% - - 75Cr
Average +2.57%+5.72%-8.25%+61.62% 1.31TCr
Weighted average by Cap. +2.49%+1.12%-27.37%+3.61%

Financials

2026 *2027 *
Net sales 1.11TCr 967.78Cr 903.53Cr 829.46Cr 1.56TCr 1,06100Cr 1.59TCr 11TCr 4.17TCr 53TCr 4.18TCr 4.09TCr 1,74600Cr 1.18TCr 1.03TCr 958.41Cr 879.84Cr 1.66TCr 1,12600Cr 1.69TCr 11TCr 4.43TCr 56TCr 4.44TCr 4.34TCr 1,85200Cr
Net income 108.07Cr 94Cr 88Cr 80Cr 151.78Cr 10TCr 154.43Cr 1.03TCr 404.94Cr 5.14TCr 405.93Cr 396.93Cr 17TCr 134.74Cr 117.11Cr 109.33Cr 100.37Cr 189.25Cr 13TCr 192.55Cr 1.29TCr 504.9Cr 6.4TCr 506.13Cr 494.91Cr 21TCr
Net Debt 259.47Cr 225.51Cr 210.54Cr 193.28Cr 364.43Cr 25TCr 370.78Cr 2.48TCr 972.27Cr 12TCr 974.63Cr 953.04Cr 41TCr 154.06Cr 133.89Cr 125Cr 114.75Cr 216.38Cr 15TCr 220.15Cr 1.47TCr 577.27Cr 7.32TCr 578.67Cr 565.85Cr 24TCr
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA